Stanley Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.1M Sell
54,119
-9,000
-14% -$3.5M 3.54% 8
2025
Q1
$27.5M Hold
63,119
5.4% 2
2024
Q4
$23.3M Buy
63,119
+21,019
+50% +$7.75M 4.53% 5
2024
Q3
$21.9M Hold
42,100
4.25% 5
2024
Q2
$22.8M Hold
42,100
4.66% 5
2024
Q1
$21.8M Buy
42,100
+5,000
+13% +$2.59M 5.43% 5
2023
Q4
$17.5M Buy
37,100
+4,000
+12% +$1.89M 4.31% 5
2023
Q3
$14.4M Hold
33,100
3.84% 6
2023
Q2
$14.7M Hold
33,100
3.98% 7
2023
Q1
$15.2M Hold
33,100
4.54% 4
2022
Q4
$17M Hold
33,100
5.39% 1
2022
Q3
$15M Hold
33,100
5.2% 1
2022
Q2
$16M Hold
33,100
5.08% 1
2022
Q1
$16.3M Buy
33,100
+2,000
+6% +$982K 4.74% 2
2021
Q4
$14.4M Buy
31,100
+1,000
+3% +$464K 4.56% 1
2021
Q3
$11.2M Buy
30,100
+2,000
+7% +$746K 4.13% 1
2021
Q2
$10.7M Sell
28,100
-1,000
-3% -$382K 4.08% 2
2021
Q1
$10.4M Buy
29,100
+4,000
+16% +$1.44M 4.16% 2
2020
Q4
$8.06M Buy
25,100
+1,000
+4% +$321K 4.05% 2
2020
Q3
$6.47M Buy
24,100
+3,200
+15% +$859K 4.49% 1
2020
Q2
$5.5M Sell
20,900
-8,000
-28% -$2.1M 3.9% 2
2020
Q1
$6.56M Sell
28,900
-16,500
-36% -$3.75M 5.06% 3
2019
Q4
$13.7M Sell
45,400
-1,700
-4% -$513K 5.82% 1
2019
Q3
$11.3M Buy
47,100
+1,200
+3% +$288K 5.53% 2
2019
Q2
$13M Buy
45,900
+5,300
+13% +$1.5M 6.24% 1
2019
Q1
$11.7M Sell
40,600
-4,300
-10% -$1.23M 5.7% 2
2018
Q4
$11.8M Hold
44,900
6.75% 1
2018
Q3
$12.3K Sell
44,900
-1,400
-3% -$384 0.09% 3
2018
Q2
$11M Hold
46,300
4.84% 2
2018
Q1
$10.2M Buy
46,300
+2,800
+6% +$615K 4.6% 1
2017
Q4
$9.79M Buy
43,500
+3,500
+9% +$788K 5.01% 2
2017
Q3
$7.6M Hold
40,000
4.24% 6
2017
Q2
$7.53M Hold
40,000
4.76% 4
2017
Q1
$6.62M Buy
40,000
+10,500
+36% +$1.74M 4.12% 6
2016
Q4
$4.24M Hold
29,500
2.91% 14
2016
Q3
$3.7M Buy
29,500
+10,000
+51% +$1.25M 2.92% 14
2016
Q2
$2.56M Buy
+19,500
New +$2.56M 2.58% 23